Sign in
Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Monday, July 13, 2026
Sign in / Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Facebook
Instagram
Twitter
Vimeo
Youtube
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Search
Tags
Immunotherapy
Tag:
immunotherapy
Healthcare
AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
BFN's Desk
-
April 13, 2026
0
Healthcare
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
BFN's Desk
-
April 1, 2026
0
Corporate
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness
BFN's Desk
-
January 15, 2026
0
Healthcare
Intas Pharmaceuticals Launches HETRONIFLYâ„¢ (Serplulimab), India's First Novel Immunotherapy for Advanced Small Cell Lung Cancer
BFN's Desk
-
August 5, 2025
0
Entertainment
Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America
BFN's Desk
-
November 3, 2023
0
Uncategorized
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral...
BFN's Desk
-
October 18, 2022
0
Entertainment
Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study presented at UEG Week suggests
BFN's Desk
-
October 9, 2022
0
Most Read
Made-in-India Skoda Kylaq Completes 19,351-km Pune-to-Prague Drive Across 13 Countries
July 10, 2026
Sahyadri Super Specialty Hospital performs autologous stem cell transplant
July 10, 2026
XECH launches SteamX Fold hybrid garment steamer
July 10, 2026
OPPO India launches Reno16 Series with AI features
July 10, 2026